Co-delivery of all-trans-retinoic acid and doxorubicin for cancer therapy with synergistic inhibition of cancer stem cells (vol 37, pg 405, 2015)

doi:10.1016/j.biomaterials.2020.120373

	Co-delivery of all-trans-retinoic acid and doxorubicin for cancer therapy with synergistic inhibition of cancer stem cells (vol 37, pg 405, 2015)
	Sun, Rong 1; Liu, Yang 2,3; Li, Shi-Yong 2,3; Shen, Song 2,3; Du, Xiao-Jiao 2,3; Xu, Cong-Fei 1; Cao, Zhi-Ting 1; Bao, Yan 2,3; Zhu, Yan-Hua 2,3; Li, Ya-Ping 5
刊名	BIOMATERIALS
	2020-12-01
卷号	263 页码:1
ISSN号	0142-9612
DOI	10.1016/j.biomaterials.2020.120373
通讯作者	Wang, Jun(jwang699@ustc.edu.cn)
WOS研究方向	Engineering ; Materials Science
语种	英语
出版者	ELSEVIER SCI LTD
WOS记录号	WOS:000582394700007
内容类型	期刊论文
源URL	[http://119.78.100.183/handle/2S10ELR8/291022]
专题	中国科学院上海药物研究所
通讯作者	Wang, Jun
作者单位	1.Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Anhui, Peoples R China 2.Univ Sci & Technol China, CAS Key Lab Innate Immun & Chron Dis, Sch Life Sci, Hefei 230026, Anhui, Peoples R China 3.Univ Sci & Technol China, Med Ctr, Hefei 230026, Anhui, Peoples R China 4.Univ Sci & Technol China, High Magnet Field Lab CAS, Hefei 230026, Anhui, Peoples R China 5.Chinese Acad Sci, Ctr Pharmaceut, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China
推荐引用方式 GB/T 7714	Sun, Rong,Liu, Yang,Li, Shi-Yong,et al. Co-delivery of all-trans-retinoic acid and doxorubicin for cancer therapy with synergistic inhibition of cancer stem cells (vol 37, pg 405, 2015)[J]. BIOMATERIALS,2020,263:1.
APA	Sun, Rong.,Liu, Yang.,Li, Shi-Yong.,Shen, Song.,Du, Xiao-Jiao.,...&Wang, Jun.(2020).Co-delivery of all-trans-retinoic acid and doxorubicin for cancer therapy with synergistic inhibition of cancer stem cells (vol 37, pg 405, 2015).BIOMATERIALS,263,1.
MLA	Sun, Rong,et al."Co-delivery of all-trans-retinoic acid and doxorubicin for cancer therapy with synergistic inhibition of cancer stem cells (vol 37, pg 405, 2015)".BIOMATERIALS 263(2020):1.